ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

REFR vs TMO // GROSS PROFIT MARGIN

Research Frontiers Incorporated (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: REFR 0 — TMO 9
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (REFR VS. TMO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC REFR TMO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 9.30% -44.30 TMO /roic <GO>
EV/EBITDA & P/E Valuation — 30.4x — TIE /valuation <GO>
Free Cash Flow Yield -10.03% 2.40% -12.43 TMO /fcf-yield <GO>
Operating Margin -60.00% 17.40% -77.40 TMO /operating-margins <GO>
Net Profit Margin -60.00% 15.10% -75.10 TMO /net-margins <GO>
Revenue Growth (YoY) -16.00% 3.90% -19.90 TMO /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.24% -0.24 TMO /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 4.50 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 8/9 -6.00 TMO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 29.5 62.9 -33.38 TMO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.94 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 36.3x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $13.3M $262.22B -$262.20B TMO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR REFR REV TMO REV REFR GROSS % TMO GROSS % REFR FCF TMO FCF
FY 2025 $1.1M $44.56B — — -$1.3M $6.29B
FY 2024 $1.3M $42.88B — — -$790.4K $7.27B
FY 2023 $909.6K $42.86B — — -$2.3M $6.48B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
REFR // BETA —
TMO // BETA 0.94